iShares Dow Jones US Medical Dev. shares owned by Oppenheimer & Co
Quarter-by-quarter ownership of iShares Dow Jones US Medical Dev. (IHI) shares owned by Oppenheimer & Co
from 13F filings
Historical chart of Oppenheimer & Co investment in iShares Dow Jones US Medical Dev.
Tip: Access up to 7 years of quarterly data
All positions including iShares Dow Jones US Medical Dev. held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in iShares Dow Jones US Medical Dev. by Oppenheimer & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $841k | 14k | 58.59 |
2023-09-30 | $2.6M | 53k | 48.50 |
2023-06-30 | $1.0M | 18k | 56.46 |
2023-03-31 | $964k | 18k | 53.98 |
2022-12-31 | $1.4M | 26k | 52.57 |
2022-09-30 | $790k | 17k | 47.17 |
2022-06-30 | $935k | 19k | 50.46 |
2022-03-31 | $1.2M | 19k | 60.96 |
2021-12-31 | $1.6M | 25k | 65.86 |
2021-09-30 | $1.4M | 22k | 62.77 |
2021-06-30 | $1.0M | 2.9k | 361.16 |
2021-03-31 | $834k | 2.5k | 330.17 |
2020-12-31 | $873k | 2.7k | 327.33 |
2020-09-30 | $1.7M | 5.8k | 299.53 |
2020-06-30 | $1.9M | 7.4k | 264.73 |
2020-03-31 | $1.9M | 8.3k | 225.38 |
2019-12-31 | $2.6M | 9.9k | 264.27 |
2019-09-30 | $7.0M | 28k | 247.24 |
2019-06-30 | $6.4M | 27k | 240.73 |
2019-03-31 | $6.3M | 27k | 231.56 |
2018-12-31 | $4.5M | 22k | 199.80 |
2018-09-30 | $5.7M | 25k | 227.50 |
2018-06-30 | $3.8M | 19k | 200.63 |
2018-03-31 | $3.2M | 17k | 184.98 |
2017-12-31 | $3.0M | 17k | 173.46 |
2017-09-30 | $2.6M | 16k | 167.01 |
2017-06-30 | $2.7M | 16k | 166.62 |
2017-03-31 | $2.3M | 16k | 151.38 |
2016-12-31 | $2.6M | 19k | 133.12 |
2016-09-30 | $7.3M | 50k | 145.38 |
2016-06-30 | $6.4M | 48k | 135.55 |
2016-03-31 | $2.0M | 17k | 122.49 |
2015-12-31 | $278k | 2.3k | 122.41 |
2015-09-30 | $253k | 2.3k | 111.40 |
2015-06-30 | $270k | 2.3k | 119.84 |
2015-03-31 | $481k | 4.0k | 120.31 |
Top funds holding iShares Dow Jones US Medical Dev.
View all funds holding iShares Dow Jones US Medical Dev.